Climate change, accompanied by air pollution, contributes to more PM, which in turn leads to more occurrences of cardiovascular problems. We can get it done within two months.”Īnother area the company plans to focus on is the rising number of health issues related to increased levels of particulate matter (PM) in the air we breathe. “In the U.S., it can take two years, maybe longer, to gain perspective with respect to status and condition,” he says, “because sometimes they’re denied effective treatment. Nuclear medicine, Billy says, can drastically shorten the diagnostic process for pulmonary conditions ranging from asthma and blood clots to lung cancer. According to Johns Hopkins Medicine, it uses “small amounts of radioactive materials, or radiopharmaceuticals, to examine organ function and structure.” NuMedTechs, as its name implies, will leverage so-called “nuclear medicine” to detect and diagnose abnormalities such as tumors, infections, hematomas, organ enlargement and cysts.
QUEST WORKSPACES TAMPA FULL
“Depending on how we evolve,” he says, “we could have a diagnostic laboratory or even a full treatment center.” But he was swayed by the robust presence of other pharma, biotech and life-sciences companies in the Tampa Bay region. Billy tells Coffee Talk he originally wanted to base NuMedTechs in Naples or Palm Beach.
The firm, the result of a merger with Canadian biotech company Pulmo Science Inc., is backed by The Econophy Group LLL, a private equity firm whose founder and CEO, M. It plans to expand into standalone space within a year or two, as it adds staff and continues to invest in research and development, software and equipment. NuMedTechs, according to a news release, will base key executives and researchers at Quest Workspaces in Tampa’s Rivergate Tower. Tampa has been chosen as the location for a recently launched biotech company that specializes in highly advanced treatments for conditions such as blood clots, tuberculosis and respiratory problems brought on by climate change.
0 kommentar(er)
